Science-driven Brand Delivers 5 Perfected Cannabis Highs
Robin Lefferts
April 6th, 2020
App, Exclusive, Top Story
What happens when the investment environment surrounding cannabis companies evaporates amid concerns about overvaluations and lack of returns? And then, a worldwide pandemic reverses years of economic growth almost overnight, plunging economies into near-instant depression? One thing that happens is some quality companies become distressed, offering investors the opportunity to purchase a stake at a greatly discounted price.
LucidMood™, a private Colorado-based company offering a variety of cannabis formulations scientifically designed to deliver the mood-enhancing effects of cannabis without the debilitating side effects. And the company was executing on a growth path, culminating in a $4 million investment from cannabis venture capitalist Gotham Green Partners in December 2018 Leveraging the success of its distinctive products in Colorado into wider distribution in other legal states, the company appeared set until a trifecta/once in a lifetime congruence of: the vape crisis while launching version 2.0, an imploding licensee in CA and finally the coronavirus, resulting in recent financing efforts falling apart. As a result, LucidMood execs have taken steep pay cuts while the company offers an investment opportunity to accredited investors.
Accredited? Click here to see the company’s deck and be contacted by LucidMood™.
Here’s the Deal
LucidMood™ is looking to raise $1 million in the short term for what is in essence one-third of the company. The current deal represents an 83% discount from the Series A financing spearheaded by Gotham Green Partners just over a year ago.
The company’s management team, led by CEO Charles Jones, believes firmly in the quality of the LucidMood products and the ability of the team to execute on its growth initiatives and past sales and acceptance by budtenders proves such. Management, already a lean group, has taken pay cuts ranging from 33% to 50% to extend resources and demonstrate faith in the business. Mr. Jones remarked in a recent conversation, “It’s important to remember that consumers will continue buying weed during the coming recession. And with cannabis stocks going down and product sales going up, this is a great time to invest in a brand – particularly one that focuses on relieving stress and anxiety.”
See an interview with LucidMood CEO Charles Jones from Sept. 2019:
Accredited? Click here to see the company’s deck and be contacted by LucidMood™.
LucidMood’s Unique Approach to Product Development
LucidMood™ approaches the product development process from a sort of reverse engineering perspective. The first question: Who is using cannabis in legal markets, and what effects or moods are people trying to achieve by using cannabis? They found a large middle ground, between stoners who wanted to get as high as possible (max THC) and medicinal users completely uninterested in the high (CBD only). Most people want the pleasantness, the inspiration, the creativity without the stupefaction, the heaviness, and the paranoia.
So they set about designing products for the variety of moods people in this middle ground were seeking. Led by neuroscientist and Chief Science Officer Tristan Watkins, Ph.D., the product development team went about formulating cannabis products to achieve those unique and disparate end goals. The result is a line of products designed to help people sleep (Lullaby), focus on the present (Luminous), relax into the mood for romance (Loving), raise their energy (Lively), and get pleasantly high (Luscious). This, from one of the pioneers and leaders of effects-based cannabis, a category which has now been universally adopted.
LucidMood™ Products Formulated by PhD Neuroscientist Tristan Watkins
Along the way, the products have been tested with real-world users and repeat customers while being adjusted accordingly. It’s not just a marketing gimmick – the products really do create differentiated effects beyond the typical Sativa/Indica divide known to most budtenders.
As LucidMood has scaled back from other states during these difficult times, products are currently available throughout the company’s home state of Colorado. The company very recently launched its products in Arizona, leveraging iAnthus’ vertically integrated supply chain in the state. Following the financing and anticipated growth, LucidMood has its eyes on Nevada as the next target market.
The Upshot
LucidMood™ thought they had it all together. Great products, a lean and energetic executive team, a reasonable plan for growth in key markets, demonstrated successes and the backing of great financiers. Along the way, of course, the bottom fell out of the capital markets and financing those plans became problematic. The result is an opportunity to invest, at a severe discount, in a cannabis company that has the potential to become a category leader in mood-based, scientifically-backed, accessible, and enjoyable cannabis products.
Accredited? Click here to see the company’s deck and be contacted by LucidMood™.
LucidMood™ Company Contact:
Charles Jones CEO
cj@lucidmood.net
CFN Media Contact:
Frank Lane President
Disclaimer
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Robin Lefferts
Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Decibel is uncompromising in the process and craftsmanship needed to deliver the highest quality cannabis products and retail experiences.
EuroMed Therapeutics is building the ninth Israeli licensed producer to capitalize on the domestic medical marijuana market and Europe’s nascent export market — worth upwards of $66 billion.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
